Abstract
We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under-recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.
Original language | English |
---|---|
Article number | e04305 |
Journal | Clinical Case Reports |
Volume | 9 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2021 |
Keywords
- adrenal insufficiency
- fever of unknown origin
- hypophysitis
- immune-related adverse events
- programmed cell death 1 protein inhibitor
ASJC Scopus subject areas
- Medicine(all)